Clinical Trial Update: Feasibility Study of Neoadjuvant Chemotherapy Modified FOLFOX6 for Resectable Liver Metastases of Colorectal Cancers [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial at Kyoto University evaluating neoadjuvant modified FOLFOX6 chemotherapy for resectable liver metastases from colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastasis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Kyoto University | Conditions: Colorectal Cancer, Liver Metastasis | Phase 2 | Status: UNKNOWN